These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 32527537)
1. Different reactivity of Sp and Rp isomers of phosphorothioate-modified oligonucleotides in a duplex structure. Islam MA; Fujisaka A; Kawakami J; Yamaguchi T; Obika S Bioorg Med Chem Lett; 2020 Jul; 30(14):127166. PubMed ID: 32527537 [TBL] [Abstract][Full Text] [Related]
2. Photomodulation of PS-modified oligonucleotides containing azobenzene substituent at pre-selected positions in phosphate backbone. Patnaik S; Kumar P; Garg BS; Gandhi RP; Gupta KC Bioorg Med Chem; 2007 Dec; 15(24):7840-9. PubMed ID: 17870546 [TBL] [Abstract][Full Text] [Related]
3. Thermal stability and conformation of antiparallel duplexes formed by P-stereodefined phosphorothioate DNA/LNA chimeric oligomers with DNA and RNA matrices. Jastrzębska K; Maciaszek A; Dolot R; Bujacz G; Guga P Org Biomol Chem; 2015 Oct; 13(39):10032-40. PubMed ID: 26293357 [TBL] [Abstract][Full Text] [Related]
4. Synthesis, biophysical properties and biological activity of second generation antisense oligonucleotides containing chiral phosphorothioate linkages. Wan WB; Migawa MT; Vasquez G; Murray HM; Nichols JG; Gaus H; Berdeja A; Lee S; Hart CE; Lima WF; Swayze EE; Seth PP Nucleic Acids Res; 2014 Dec; 42(22):13456-68. PubMed ID: 25398895 [TBL] [Abstract][Full Text] [Related]
9. Stereocontrolled synthesis of oligoribonucleoside phosphorothioates by an oxazaphospholidine approach. Oka N; Kondo T; Fujiwara S; Maizuru Y; Wada T Org Lett; 2009 Feb; 11(4):967-70. PubMed ID: 19159256 [TBL] [Abstract][Full Text] [Related]
10. 2'- Honcharenko D; Rocha CSJ; Lundin KE; Maity J; Milton S; Tedebark U; Murtola M; Honcharenko M; Slaitas A; Smith CIE; Zain R; Strömberg R Nucleic Acid Ther; 2022 Jun; 32(3):221-233. PubMed ID: 35238623 [TBL] [Abstract][Full Text] [Related]
11. Effect of diastereoisomeric composition on the chromatographic retention of phosphorothioated oligonucleotides using three different liquid chromatography systems. Roussis SG; Wan WB; Rentel C J Chromatogr A; 2024 Aug; 1730():465108. PubMed ID: 38941798 [TBL] [Abstract][Full Text] [Related]
12. Impact of Oligonucleotide Structure, Chemistry, and Delivery Method on In Vitro Cytotoxicity. Janas MM; Jiang Y; Schlegel MK; Waldron S; Kuchimanchi S; Barros SA Nucleic Acid Ther; 2017 Feb; 27(1):11-22. PubMed ID: 27923110 [TBL] [Abstract][Full Text] [Related]
13. Control of phosphorothioate stereochemistry substantially increases the efficacy of antisense oligonucleotides. Iwamoto N; Butler DCD; Svrzikapa N; Mohapatra S; Zlatev I; Sah DWY; Meena ; Standley SM; Lu G; Apponi LH; Frank-Kamenetsky M; Zhang JJ; Vargeese C; Verdine GL Nat Biotechnol; 2017 Sep; 35(9):845-851. PubMed ID: 28829437 [TBL] [Abstract][Full Text] [Related]
14. Stereo-Controlled Liquid Phase Synthesis of Phosphorothioate Oligonucleotides on a Soluble Support. Rosenqvist P; Saari V; Pajuniemi E; Gimenez Molina A; Ora M; Horvath A; Virta P J Org Chem; 2023 Jul; 88(14):10156-10163. PubMed ID: 37428953 [TBL] [Abstract][Full Text] [Related]
15. Copper-Catalyzed Huisgen 1,3-Dipolar Cycloaddition Tailored for Phosphorothioate Oligonucleotides. Honcharenko M; Honcharenko D; Stromberg R Curr Protoc Nucleic Acid Chem; 2020 Mar; 80(1):e102. PubMed ID: 31884728 [TBL] [Abstract][Full Text] [Related]
16. Hybridizing ability and nuclease resistance profile of backbone modified cationic phosphorothioate oligonucleotides. Rahman SM; Baba T; Kodama T; Islam MA; Obika S Bioorg Med Chem; 2012 Jul; 20(13):4098-102. PubMed ID: 22658536 [TBL] [Abstract][Full Text] [Related]
17. Significance of stereochemistry of 3'-terminal phosphorothioate-modified primer in DNA polymerase-mediated chain extension. Nawrot B; Paul N; Rebowska B; Stec WJ Mol Biotechnol; 2008 Oct; 40(2):119-26. PubMed ID: 18769882 [TBL] [Abstract][Full Text] [Related]
18. Development of an ICP-MS/MS approach for absolute quantification and determination of phosphodiester to phosphorothioate ratio in therapeutic oligonucleotides. Bianga J; Perez M; Mouvet D; Cajot C; De Raeve P; Delobel A J Pharm Biomed Anal; 2020 May; 184():113179. PubMed ID: 32092633 [TBL] [Abstract][Full Text] [Related]
19. Impact of Phosphorothioate Chirality on Double-Stranded siRNAs: A Systematic Evaluation of Stereopure siRNA Designs. Sakamuri S; Eltepu L; Liu D; Lam S; Meade BR; Liu B; Dello Iacono G; Kabakibi A; Luukkonen L; Leedom T; Foster M; Bradshaw CW Chembiochem; 2020 May; 21(9):1304-1308. PubMed ID: 31863714 [TBL] [Abstract][Full Text] [Related]